Yes, Pradaxa has some problems. If Portola’s FXa antidote that BMY/PFE are now supporting pans out (#msg-81069705), it’ll be game over for Pradaxa, IMO.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”